share_log

公告精选 | 理想汽车下调Q1预计交付量;中海油2023年营收净利双双下滑

Featured announcements | Ideal Auto cuts estimated delivery volume in Q1; CNOOC's net revenue and profit both declined in 2023

cls.cn ·  Mar 22 07:57

Source: Finance Association

The important announcements for Hong Kong stocks yesterday are as follows:

Results Express

$CHINA MOBILE (00941.HK)$: In 2023, revenue was 1009.3 billion yuan, up 7.7% year on year, and net profit was 131.8 billion yuan, up 5.0% year on year.

$PING AN (02318.HK)$: Total revenue in 2023 was 1031,863 billion yuan, up 4.74% year-on-year, and net profit of 85.665 billion yuan.

$CNOOC (00883.HK)$: 2023 revenue of 416.609 billion yuan, a year-on-year decrease of 1.33%; net profit of 123.843 billion yuan, a decrease of 12.6% year-on-year.

According to reports, the year-on-year decline in net profit due to the company's continuous increase in storage and production, improving quality and efficiency, effectively resisting the adverse effects of falling international oil prices.

$CKH HOLDINGS (00001.HK)$: Total revenue in 2023 was HK$461,558 billion, up 0.95% year on year, and net profit of HK$23.5 billion, down 8.71% year on year.

$CK ASSET (01113.HK)$: Revenue of HK$47.243 billion in 2023, a year-on-year decrease of 16.15%, and net profit of HK$17.34 billion, a decrease of 20.03% year-on-year.

$HENDERSON LAND (00012.HK)$: Revenue of HK$27.57 billion in 2023, up 7.9% year on year, and net profit of HK$9.261 billion, up 0.24% year on year.

$OOIL (00316.HK)$: 2023 revenue of US$8.344 billion, a year-on-year decrease of 57.9%, and net profit of US$1,368 billion, a year-on-year decrease of 86.27%.

$MGM CHINA (02282.HK)$: Operating revenue of HK$24.684 billion in 2023, up 368.52% year on year, and net profit of HK$2,638 million, turning a year-on-year loss into a profit.

For the year ended December 31, 2023, the Group's operating revenue performance was superior to the market, up 8.4% from the same period before the COVID-19 outbreak in 2019.

$CHINA STATE CON (03311.HK)$: 2023 revenue of HK$113.734 billion, up 11.53% year on year, and net profit of HK$9.164 billion, up 15.17% year on year.

$CHINA RUYI (00136.HK)$: Revenue is expected to reach $3.45 billion to $4 billion in 2023, up about 161.4% to 203.0% year-on-year. Adjusted profit was 9.3 billion yuan to 1.08 billion yuan, up about 257.7% to 315.4% year on year.

$SUNAC (01918.HK)$: The annual shareholders' share loss is estimated at 7 billion yuan to 9 billion yuan, a significant improvement over the previous year.

$ZENGAME (02660.HK)$: Revenue of 2023 was 2,059 billion yuan, up 16.52% year on year, and net profit of 726 million yuan, up 6.62% year on year.

$HENLIUS (02696.HK)$: In 2023, revenue was 5.395 billion yuan, up about 67.8% year on year, and net profit was 546 million yuan, turning a year-on-year loss into a profit.

$COWELL (01415.HK)$: In 2023, revenue reached about US$924 million, a year-on-year decrease of about 17.23%, and net profit of about US$46.589 million, a year-on-year decrease of about 44.74%.

Company news

$CHINA CRSC (03969.HK)$: In the first two months, it won bids for six important projects in the rail transit market, involving 2,316 billion yuan. It accounts for approximately 5.76% of the audited revenue in 2022.

$LI AUTO-W (02015.HK)$: Due to sales orders falling short of expectations, vehicle deliveries are expected to be 76,000 to 78,000 units in the first quarter of 2024, compared to the previous delivery volume of 100,000 to 103,000 vehicles.

$SH PHARMA (02607.HK)$: Amiodarone hydrochloride injection approved for production. According to the IQVIA database, the hospital market size of amiodarone hydrochloride injection in 2023 is RMB 20.78 million.

Stock and repurchase trends

$TENCENT (00700.HK)$: A total of approximately 6.065,500 shares were issued due to the exercise of options by its employees under the share option plan. On the same day, approximately 230.47 million new shares were issued under the share award scheme adopted on May 17, 2023.

$FOURTH PARADIGM (06682.HK)$: The plan is to seek to repurchase the company's shares on the open market from time to time, with a total amount not exceeding HK$300 million.

$HSBC HOLDINGS (00005.HK)$: HK$110 million was spent to repurchase 1,8396 million shares at a repurchase price of HK$59.6-59.8.

$SWIRE PACIFIC A (00019.HK)$: Approximately HK$14.173,500 was spent to repurchase 221,000 shares at a repurchase price of HK$63.55-HK$64.50.

$KUAISHOU-W (01024.HK)$: A repurchase of 391,000 shares was spent at HK$1995,000.

$3SBIO (01530.HK)$: The board recommended share repurchase. According to the 2023 repurchase authorization, the company was allowed to repurchase up to 244 million shares.

edit/lambor

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment